RYGANVI
Live / Allowed — First extension granted (statement of use) (as of 13 May 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99213664
- Mark type
- Word mark
- Filed
- 02 Jun 2025
- Published for opposition
- 23 Sept 2025
- Attorney of record
- Gregory Zinkl
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in neurological disorders including Alzheimer's
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 14 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 May 2026 — SOU EXTENSION 1 GRANTED
- 13 May 2026 — SOU EXTENSION 1 FILED
- 13 May 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Apr 2026 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 10 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Apr 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Apr 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Apr 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Apr 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Sept 2025 — PUBLISHED FOR OPPOSITION
- 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER